A leading medical device and software company focused on skin health with its SIAscopy™ on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology
We’re pleased to announce that Dr. Trevor Champagne has been appointed Chair of our Medical Advisory Board. It’s with guidance from world-class medical professionals like @tjc78 and others that MedX has become a leader in #teledermatology.
https://t.co/jRQXzgTKNu
"Detecting #skincancer is an enormous global need and #MedXHealth is working hard to fill this need. #MedX has the right device and approvals in 35 countries" https://t.co/dtOAAz22Yc #Melanoma#Telemedicine $MDX.V
"#Telemedicine will have long term, sustainable growth and the #MedX’s tele-dermatology platform is a “Gold Standard” in telemedicine for the #dermatological market space.” https://t.co/EcXZU5uBlh
#MedXHealth Provides Update on the Release of Its First Quarter 2020 Interim Financial Statements and Related Disclosures, and Retirement of a Director https://t.co/Pz7E7kPNGl $MDX.V
#SkinCancer screenings save lives - Have a look at our #SIAscopy technology which is a non-invasive skin screening procedure for #moles and #lesions https://t.co/v5xHUawKRi #Melanoma
For the first time, physicians can more accurately evaluate suspicious #moles and #lesions in a non-invasive, pain-free way. Know more about the benefits of our technology. https://t.co/v5xHUaOmfS #Cancer#SkinCancer#Melanoma